Cargando…
The role of ultrasonographic findings for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer
To determine whether ultrasound (US) features of breast cancer are associated with Breast Imaging and Reporting Data System molecular subtype, histologic grade, and hormone receptor status as well as to assess the predictive value of these features. Retrospective analysis of the medical records of 2...
Autores principales: | Li, Shuo, Zhang, Qi-Li, Guo, Rui-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655685/ https://www.ncbi.nlm.nih.gov/pubmed/38025526 http://dx.doi.org/10.1515/med-2023-0725 |
Ejemplares similares
-
Patient-Reported Outcomes in Patients With PIK3CA-Mutated Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer From SOLAR-1
por: Ciruelos, Eva Maria, et al.
Publicado: (2021) -
PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer
por: Fusco, Nicola, et al.
Publicado: (2021) -
PIK3CA Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
por: Rasti, Aryana R., et al.
Publicado: (2022) -
PIK3CA mutation inhibition in hormone receptor-positive breast cancer: time has come
por: De Mattos-Arruda, Leticia
Publicado: (2020) -
PIK3CA co-occurring mutations and copy-number gain in hormone receptor positive and HER2 negative breast cancer
por: Migliaccio, Ilenia, et al.
Publicado: (2022)